Valuation: Cegedim

Market Cap 140M 160M 129M 119M 224M 15.37B 229M 1.54B 605M 7.53B 600M 586M 25.92B P/E 2026 *
6.92x
P/E 2027 * 4.6x
Enterprise Value 318M 363M 293M 270M 509M 35B 521M 3.5B 1.38B 17.14B 1.37B 1.34B 59.02B EV / Sales 2026 *
0.48x
EV / Sales 2027 * 0.42x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day-56.91%
1 week+14.62%
Current month+15.28%
1 month+4.20%
3 months-2.02%
6 months-12.27%
Current year-9.33%
1 month 10.54
Extreme 10.54
12.15
Current year 8.6
Extreme 8.6
14.8
1 year 8.6
Extreme 8.6
14.8
3 years 8.6
Extreme 8.6
22.15
5 years 8.6
Extreme 8.6
29.75
10 years 8.6
Extreme 8.6
42.5
Manager TitleAgeSince
Chief Executive Officer 83 2009-10-24
Director of Finance/CFO - 2016-06-13
Corporate Officer/Principal 55 2015-11-25
Director TitleAgeSince
Chairman 83 2009-10-24
Director/Board Member 70 2016-06-13
Director/Board Member 72 2010-08-08
Change 5-day change 1-year change 3-year change Capi.($)
-56.91%+14.62% - - 160M
+1.77%-10.12%-49.18%+6.33% 364B
+0.20%+0.25%-48.11%+7.41% 184B
-0.74%-4.15%-46.18%-12.86% 106B
-0.87%-0.05%-44.43%+1.79% 42.36B
+0.87%+0.22%-78.98%+110.83% 33.81B
+1.28%+0.50%-17.58%+50.15% 29.15B
-0.82%+2.59%-35.48%+16.36% 17.44B
-1.92%-0.19%-35.72%-1.86% 12.29B
+0.75%+10.20%-32.16%+88.68% 12.49B
Average -5.87%-0.08%-43.09%+29.65% 89.16B
Weighted average by Cap. -0.21%-4.85%-47.63%+11.16%

Financials

2026 *2027 *
Net sales 660M 756M 609M 562M 1.06B 72.78B 1.08B 7.28B 2.87B 35.64B 2.84B 2.78B 123B 681M 779M 629M 579M 1.09B 75.06B 1.12B 7.51B 2.96B 36.76B 2.93B 2.86B 127B
Net income 21.25M 24.32M 19.61M 18.07M 34.07M 2.34B 34.82M 234M 92.19M 1.15B 91.32M 89.32M 3.95B 30.58M 35M 28.22M 26.01M 49.03M 3.37B 50.12M 337M 133M 1.65B 131M 129M 5.68B
Net Debt 178M 204M 164M 152M 286M 19.63B 292M 1.96B 773M 9.61B 766M 749M 33.1B 150M 171M 138M 127M 240M 16.5B 245M 1.65B 650M 8.08B 644M 629M 27.82B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
10.16EUR
Average target price
15.00EUR
Spread / Average Target
+47.64%

Quarterly revenue - Rate of surprise